Injured by Zyprexa Side Effects?
Breaking News: The drug maker Eli Lilly has engaged in a decade-long effort to play down the health risks (Diabetes, Hyperglycemia, Ketoacidosis, Pancreatitis, and in some cases diabetic coma or death) of Zyprexa, its best-selling medication for schizophrenia, according to hundreds of internal Lilly documents and e-mail messages among top company managers >>> Read More
The popular atypical antipsychotic drug Zyprexa (Generic: olanzapine) used by millions of Americans to Schizophrenia and bipolar disorder has been linked to, high blood sugar and Diabetes, Hyperglycemia, Ketoacidosis, Pancreatitis, Neuroleptic Malignant Syndrome (NMS), Tardive Dyskinesia (TD), Diabetic Comas and death.
Update: Schmidt & Clark is no longer accepting Zyprexa cases.
What is the problem?
Zyprexa is a drug marketed by Eli Lilly and is in a class of drugs called atypical antipsychotics, which are used to treat schizophrenia, bipolar disorder, anxiety and sleep disorders.
Eli Lilly, has been instructed by the Food and Drug Administration (FDA) to place new warnings on labels and packaging to the commonly used schizophrenia drug Zyprexa.
Zyprexa has been linked to diabetes and multiple blood sugar level disorders. Recent study shows atypical antipsychotic drugs like Zyprexa used in treatment of schizophrenia, appear to cause diabetes at a rate nearly 50 percent higher than previous generation drugs.
Zyprexa Side Effects
The FDA has issued a public health advisory regarding the following serious and life-threatening adverse side effects of Zyprexa:
- Diabetes
- Hyperglycemia
- Ketoacidosis
- Pancreatitis
- Diabetic coma
- Death
Zyprexa Side Effects & Lawsuit News (National)
| Eli Lilly settles Zyprexa investigations - CNN Money INDIANAPOLIS (AP) -- Drugmaker Eli Lilly & Co. cleared another legal cloud hanging over its top-selling drug Zyprexa when it announced a $62 million settlement Tuesday, but several other storms are still brewing for the antipsychotic medication ... Eli Lilly settles Zyprexa inquiries in US states - International Herald Tribune INDIANAPOLIS : Drugmaker Eli Lilly & Co. cleared another legal cloud hanging over its top-selling drug Zyprexa when it announced a $62 million settlement Tuesday, but several other storms are still brewing for the antipsychotic medication. Lilly ... Eli Lilly settles Zyprexa inquiries in 32 states - Washington Post Resize NEW YORK -- Eli Lilly & Co. said Tuesday it will pay $62 million to resolve investigations into the marketing and promotion of its antipsychotic drug Zyprexa in 32 states and Washington, D.C. The payments will be divided between the states ... Lilly Settles 32 State Zyprexa Probes for $62 Million (Update2) - Bloomberg Oct. 7 (Bloomberg) -- Eli Lilly & Co. settled an investigation by 32 states into the promotion, marketing and sale of its top-selling antipsychotic medication Zyprexa for $62 million, the company said today. The states were looking into claims that ... E.Lilly to pay $62 mln to settle Zyprexa case -NYT - Reuters Oct 7 (Reuters) - Eli Lilly and Co (LLY.N: Quote , Profile , Research , Stock Buzz ) has agreed to pay $62 million to settle claims that it improperly marketed its blockbuster schizophrenia drug, Zyprexa, to patients who were not approved users, the ... Lilly to pay $62M in 32-state Zyprexa settlement - Indianapolis Star Eli Lilly and Co. will pay $62 million to 32 states to settle an investigation into improper marketing of top-selling drug Zyprexa. The settlement, to be announced today, is the largest-ever multistate consumer protection action against a drug ... Lilly Paying $62 Million to Settle State Zyprexa Investigations - Wall Street Journal Lilly said this morning that it?s cut a $62 million deal with 32 states that have been investigating the company over its marketing of the antipsychotic drug Zyprexa. But several other government investigations are still ongoing, which means the ... Eli Lilly (LLY) Resolves Multi-State Investigation Into Zyprexa - StreetInsider.com Eli Lilly and Company (NYSE: LLY ) has resolved a multi-state investigation involving 32 states and the District of Columbia (DC) related to the sales, marketing and promotion of its antipsychotic medication Zyprexa® (olanzapine). While there is no ... Eli Lilly agrees to buy ImClone for more than $6B - Washington Post INDIANAPOLIS -- Eli Lilly & Co. has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand Lilly's cancer treatment pipeline a few years before several patent expirations hit the drug maker. New ... Shurtleff foe questions contract for law firm - Salt Lake Tribune To many, they're known as the phone book guys because of their ads plastered on the back covers of the white and yellow pages. But now the personal injury firm of Siegfried & Jensen has its hands in some of the most high-profile lawsuits to come Utah ... |
